Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative radiotherapy.

A M Awan1, R R Weichselbaum

  • 1Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Illinois.

Hematology/Oncology Clinics of North America
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.

Scientific reports·2016
Same author

Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.

Leukemia & lymphoma·2016
Same author

Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.

Oncogene·2016
Same author

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.

British journal of cancer·2015
Same author

Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.

Oncogene·2014
Same author

Optimizing management of colorectal hepatic metastases: now and in the future.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2014
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Radiation therapy effectively palliates symptoms and suffering in non-small cell lung cancer patients. This treatment offers wide applicability with minimal side effects, providing prompt relief for patients with limited life expectancy.

Area of Science:

  • Oncology
  • Palliative Care

Background:

  • Non-small cell lung cancer (NSCLC) presents significant symptom burden.
  • Palliative care aims to improve quality of life for patients with advanced cancer.

Purpose of the Study:

  • To review the role of radiation therapy in palliative treatment for NSCLC patients.
  • To assess the efficacy and applicability of radiation therapy in symptom management.

Main Methods:

  • Literature review on radiation therapy for palliative NSCLC treatment.
  • Analysis of symptom palliation, including chest symptoms, metastases, and neurologic complications.

Main Results:

  • Radiation therapy effectively palliates dyspnea, cough, hemoptysis, and chest pain.
  • Skeletal and hepatic metastases pain is alleviated with minimal morbidity.

Related Experiment Videos

  • Neurologic complications from cerebral metastases and spinal cord compression are reduced.
  • Radiation therapy is broadly applicable across performance statuses.

    • Conclusions:

    • Radiation therapy is a potent palliative modality for NSCLC patients, relieving suffering effectively.
    • Prompt intervention with optimized radiation schedules minimizes treatment time and maximizes efficacy.
    • Treatment offers rapid palliation with minimal side effects and low long-term risk for patients with limited life expectancy.